Go Deep
BioLife Solutions Inc
BioLife Solutions Inc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,931 | 39.0 | 4.50 | 0.04 | 3,729.28 |
| Oct 2026 | 18,905 | 39.0 | 4.50 | 0.04 | 3,696.54 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,676.97 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,665.92 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,666.45 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,656.94 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,660.86 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,660.86 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,651.82 |
| Oct 2026 | 18,924 | 39.0 | 4.50 | 0.04 | 3,644.43 |
BioLife Solutions Inc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 28,466,000.0 | 27,500,000.0 | 18,785,000.0 | 28,067,000.0 |
| Net Profit | 45,104,000.0 | 1,186,000.0 | 11,070,000.0 | 621,000.0 |
| EPS | 0.9 | 0.0 | 0.2 | 0.0 |
BioLife Solutions Inc Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 96,214,000.0 | 74,647,000.0 | 68,016,000.0 | 76,239,000.0 | — |
| Net Profit | -4,595,000.0 | -20,184,000.0 | -68,002,000.0 | -139,805,000.0 | — |
| EPS | -0.1 | -0.4 | -1.6 | -3.3 | — |
BioLife Solutions Inc Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 405,884,000.0 | 399,487,000.0 | 412,714,000.0 | 450,229,000.0 | — |
| Total Liabilities | 33,996,000.0 | 50,578,000.0 | 75,051,000.0 | 86,041,000.0 | — |
| Total Equity | 371,888,000.0 | 348,909,000.0 | 337,663,000.0 | 364,188,000.0 | — |
Owes vs Owns
BioLife Solutions Inc owed $0.06 for every $1 it owned in Jun 2026, down from $0.19 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.06× | 0.08× | 0.13× | 0.18× | 0.19× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
BioLife Solutions Inc Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 21.9%Receivables 2.0%Inventory 7.4%Fixed assets (tangible) 5.5%Intangible assets 52.4%Long-term investments 7.7%Other assets 3.1%
How it's funded — Dec 2025
Short-term debt 1.2%Long-term debt 2.6%Other liabilities 4.2%Shareholders' equity 91.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 88.9 | 100.7 | 44.2 | 62.7 |
| Receivables | 8.0 | 8.5 | 7.9 | 33.9 |
| Inventory | 30.2 | 29.0 | 27.2 | 34.9 |
| Fixed assets (tangible) | 22.2 | 16.5 | 12.6 | 39.2 |
| Intangible assets | 212.8 | 214.2 | 224.3 | 256.8 |
| Long-term investments | 31.2 | 5.6 | 5.6 | 6.4 |
| Other assets | 12.6 | 25.0 | 91.0 | 16.3 |
| Liabilities & equity | ||||
| Short-term debt | 5.0 | 10.9 | 6.3 | 1.8 |
| Long-term debt | 10.7 | 5.0 | 17.6 | 23.8 |
| Payables | 1.5 | 3.4 | 2.3 | 15.4 |
| Other liabilities | 16.9 | 31.3 | 48.9 | 45.1 |
| Shareholders' equity | 371.9 | 348.9 | 337.7 | 364.2 |
| Net tangible assets | 159.0 | 134.8 | 113.4 | 107.4 |
BioLife Solutions Inc Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 20,115,000.0 | 8,431,000.0 | -12,498,000.0 | -8,488,000.0 | — |
| Investing Activities | -71,539,000.0 | 58,300,000.0 | 17,837,000.0 | -58,117,000.0 | — |
| Financing Activities | -10,924,000.0 | -6,783,000.0 | 10,591,000.0 | 16,316,000.0 | — |